The Notice of Allowance for the patent application suggests that Hoth Therapeutics is likely to secure a patent, which could enhance its intellectual property portfolio. This development is significant as it pertains to a potential treatment for Alzheimer's, a major health issue. The news is likely to positively impact Hoth's stock price in the short term as it strengthens the company's market position and future prospects.